Trial Profile
Phase II Trial of Caelyx and Cyclophosphamide in Metastatic Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 06 Nov 2008 New trial record.